First medicine for HIV pre-exposure prophylaxis recommended for approval in the EU

View source ↗

Summary

The EU medicines agency recommends approval of the first medicine for HIV pre-exposure prophylaxis (PrEP) in the European Union.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• to be confirmed by EMA decision